Javascript is disabled or is not supported by your browser. Please upgrade your browser or enable Javascript to navigate the interface properly.

Perbak Capital Partners »

Regeneron Pharmaceuticals shares owned by Perbak Capital Partners

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Perbak Capital Partners from 13F filings

Historical chart of Perbak Capital Partners investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Perbak Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csv

Download consolidated filings csv

Download as Excel

Download consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Perbak Capital Partners

Quarter filed	Position value	Share count	Share price at filing
2025-09-30	$1.1M	2.0k	562.27
2025-06-30	$613k	1.2k	525.00
2024-06-30	$683k	650	1051.03

More positions owned by Perbak Capital Partners

Select Sector Spdr Tr Indl (XLI)

Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)

Select Sector Spdr Tr Sbi Cons Stpls (XLP)

Spdr S&p 500 Etf Tr Tr Unit (SPY)

Select Sector Spdr Tr Sbi Healthcare (XLV)

Ishares Tr Russell 2000 Etf (IWM)

Spdr Series Trust S&p Ins Etf (KIE)

Select Sector Spdr Tr Technology (XLK)

Elanco Animal Health (ELAN)

Ishares Tr Ishares Semicdtr (SOXX)

Select Sector Spdr Tr Financial (XLF)

Ubs Group SHS (UBS)

Qiagen Nv Com Shs (QGEN)

D.R. Horton (DHI)

Mettler-Toledo International (MTD)

View all positions for Perbak Capital Partners

Top funds holding Regeneron Pharmaceuticals

State Street Corporation

Jpmorgan Chase & Co

Geode Capital Management

Franklin Resources

Capital World Investors

Loomis, Sayles and

Susquehanna International

Goldman Sachs Group

View all funds holding Regeneron Pharmaceuticals

© 2025 stockzoa - Track 13F-HR Filings for Hedge Funds and Value Investors.

Disclaimers: stockzoa.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on stockzoa.com represent a recommendation to purchase or sell a stock. The information on this site is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall stockzoa.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content available on stockzoa.com, or relating to the use of, or inability to use, stockzoa.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

Fund Directory: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X-Z